Javad Razaviyan
Overview
Explore the profile of Javad Razaviyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razaviyan J, Sirati-Sabet M, Hadavi R, Karima S, Rajabi Bazl M, Mohammadi-Yeganeh S
Curr Med Chem
. 2024 Nov;
PMID: 39484777
Introduction: Triple-Negative Breast Cancer (TNBC) is the most common type of breast cancer (BC). In order to develop effective treatments for TNBC, it is vital to identify potential therapeutic targets....
2.
Razaviyan J, Sirati-Sabet M, Tafti A, Hadavi R, Karima S, Rajabibazl M, et al.
Endocr Metab Immune Disord Drug Targets
. 2024 Feb;
24(14):1664-1676.
PMID: 38424419
Background: The most aggressive form of breast cancer (BC) is Triple-Negative BC (TNBC), with the poorest prognosis, accounting for nearly 15% of all cases. Since there is no effective treatment,...
3.
Tamtaji O, Derakhshan M, Rashidi Noshabad F, Razaviyan J, Hadavi R, Jafarpour H, et al.
Front Cell Dev Biol
. 2022 Feb;
9:792185.
PMID: 35111757
A major terrifying ailment afflicting the humans throughout the world is brain tumor, which causes a lot of mortality among pediatric and adult solid tumors. Several major barriers to the...
4.
Hadavi R, Mohammadi-Yeganeh S, Razaviyan J, Koochaki A, Kokhaei P, Bandegi A
Galen Med J
. 2021 Sep;
8:e1646.
PMID: 34466540
Background: Triple-negative breast cancer (TNBC) is an invasive and lethal form of breast cancer. PI3K pathway, which often activated in TNBC patients, can be a target of miRNAs. The purpose...
5.
Pourfridoni M, Abbasnia S, Shafaei F, Razaviyan J, Heidari-Soureshjani R
Biomed Res Int
. 2021 May;
2021:6667047.
PMID: 33937408
The novel coronavirus disease 2019 (COVID-19) is the cause of an acute respiratory illness which has spread around the world. The virus infects the host by binding to the angiotensin-converting...
6.
Omrani V, Koochaki A, Behzad S, Kia V, Ghasemi P, Razaviyan J, et al.
Anticancer Agents Med Chem
. 2021 Apr;
22(7):1386-1396.
PMID: 33845752
Background: Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancer (BC) cases and is a severe type of BC. Since medicinal herbs containing biocompatible substances that are accepted...
7.
Pishkari S, Hadavi R, Koochaki A, Razaviyan J, Paryan M, Hashemi M, et al.
Horm Mol Biol Clin Investig
. 2021 Mar;
42(3):265-271.
PMID: 33769725
Objectives: The aim of the present study was to investigate the expression of and genes and their targeting microRNAs (miRNAs) including miR-34a and miR-144 in Medullary Thyroid Carcinoma (MTC) cell...
8.
Borran S, Ahmadi G, Rezaei S, Anari M, Modabberi M, Azarash Z, et al.
Pathol Res Pract
. 2020 Sep;
216(10):153217.
PMID: 32987339
The prevalence of thyroid cancer the most frequent endocrine malignancy, is rapidly increasing. Most of thyroid cancers are relatively indolent, however, some cases still possess a risk of developing into...
9.
Shabani N, Razaviyan J, Paryan M, Tavangar S, Azizi F, Mohammadi-Yeganeh S, et al.
Hum Pathol
. 2018 Jun;
79:212-221.
PMID: 29885402
Medullary thyroid carcinoma (MTC) is a rare neoplasia derived from neural parafollicular C cells. MicroRNAs (miRNAs) are small regulatory RNAs with essential roles in the biology of cancers such as...
10.
Razaviyan J, Hadavi R, Tavakoli R, Kamani F, Paknejad M, Mohammadi-Yeganeh S
Appl Biochem Biotechnol
. 2018 Jun;
186(4):1074-1089.
PMID: 29862445
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer. Aberrant expression of genes in mTOR pathway and their targeting miRNAs plays an important role in TNBC. The...